Isis Pharmaceuticals: Kynamro's Approval Is An Antisense Home Run.

ISIS is iCo's partner and the lead 007 asset is the same RNA anti-sense technology! This is massive moving forward for iCo and thier lead asset.

Many are saying that this is the year of the anti sense...

http://seekingalpha.com/article/1142891-isis-pharmaceuticals-kynamro-s-approval-is-an-antisense-home-run?source=email_rt_article_title